Discussion of the Brazilian neurologists about sudden unexpected death in epilepsy.


Journal

Revista da Associacao Medica Brasileira (1992)
ISSN: 1806-9282
Titre abrégé: Rev Assoc Med Bras (1992)
Pays: Brazil
ID NLM: 9308586

Informations de publication

Date de publication:
May 2022
Historique:
received: 14 01 2022
accepted: 23 01 2022
entrez: 18 5 2022
pubmed: 19 5 2022
medline: 21 5 2022
Statut: ppublish

Résumé

This study aimed to evaluate the concept of health professionals affiliated with the Brazilian League of Epilepsy on whether or not to inform patients about the risk factors related to the occurrence of sudden unexpected death in epilepsy. A descriptive research of inquiry was conducted with direct survey on the Brazilian neurologist's view, regarding medical behavior in the health area to report or not about the risk of sudden unexpected death in epilepsy. Data collection consisted of a structured questionnaire available online. The study population consisted of a sample of 44 Brazilian League of Epilepsy members who answered the questionnaire, of which 25 (56.8%) were men and 19 (43.2%) were women. Among the analyzed questionnaires, 79.5% reported that they were aware of the risk factors for sudden unexpected death in epilepsy and 18.2% admitted not knowing the potential risk factors for sudden unexpected death in epilepsy. Notably, 59.1% of these professionals thought that an early discussion with the patient about sudden unexpected death in epilepsy must be considered. The majority (70%) felt that the neurologist should do this, and 22% believed that the subject should be discussed with psychologists. It was noted that 84.1% of respondents did not discuss or discussed only with some of their patients about the risk factors for sudden unexpected death in epilepsy. There is a need for encouraging early discussion of sudden unexpected death in epilepsy with epilepsy patients if the patient asks about the risks related to epilepsy and its treatment, when treatment adherence is low, in cases of intractable epilepsy with strong indication for surgical treatment, and when polytherapy is needed.

Identifiants

pubmed: 35584495
pii: S0104-42302022000500675
doi: 10.1590/1806-9282.20220063
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

675-679

Auteurs

Amanda Mosini (A)

Associação Brasileira de Epilepsia - São Paulo (SP), Brazil.
Universidade Federal de São Paulo, Departamento de Fisiologia - São Paulo (SP), Brazil.

Ively Guimarães Abdalla (IG)

Escola Paulista de Medicina/Universidade Federal de São Paulo, Disciplina de Neurologia Experimental - São Paulo (SP), Brazil.

Michele Longoni Calió (ML)

Universidade Federal de São Paulo, Departamento de Fisiologia - São Paulo (SP), Brazil.

Ana Claudia Fiorini (AC)

Escola Paulista de Medicina/Universidade Federal de São Paulo, Departamento de Fonoaudiologia - São Paulo (SP), Brazil.

Carla Alessandra Scorza (CA)

Escola Paulista de Medicina/Universidade Federal de São Paulo, Disciplina de Neurologia Experimental - São Paulo (SP), Brazil.

Maria Alice Susemihl (MA)

Associação Brasileira de Epilepsia - São Paulo (SP), Brazil.

Josef Finsterer (J)

Messerli Institute, Klinikum Landstrasse - Vienna, Austria.

Fúlvio Scorza (F)

Escola Paulista de Medicina/Universidade Federal de São Paulo, Disciplina de Neurologia Experimental - São Paulo (SP), Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH